ABVC BioPharma Profit Margin

The latest profit margin for ABVC is 59.58% as of June 2026. That compares with -800.57% in the prior-year period — up 107.4% year over year. That is above the Industrials sector average of 4.71%. Investors often review this figure alongside ABVC BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABVC's profit margin moved from -800.57% to 59.58% — a 107.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ABVC BioPharma's valuation or profitability profile.

Against Industrials companies, ABVC currently prints 59.58% for profit margin, while the sector average sits near 4.71%. That is roughly 1166.3% above the sector mean. Large gaps often invite a closer look at ABVC BioPharma's growth, margins, and balance sheet.

Profit Margin shows how effectively ABVC BioPharma converts resources into returns. At 59.58%, ABVC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -800.57% in the prior-year period — up 107.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABVC's profit margin (59.58%), review year-over-year change from -800.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.